Warning letters, 483s, Recalls, Import Alerts, Audit observations
Indian drug regulator CDSCO (Central Drugs Standards Control Organisation) has published the Not of Standard
The Central Drugs Standard Control Organisation (CDSCO) has published the NSQ (Not of Standard Quality)
In December 2024, the Indian drug regulator, CDSCO, flagged 51 drugs as Not of Standard
The Indian drug regulator, CDSCO, has published a list of spurious drugs detected in November
The Central Drugs Standard Control Organization (CDSCO) has issued a spurious drug alert for popular
In September 2024, the European Commission (EC) revoked the Conditional Marketing Authorisation (CMA) for Advanz
USFDA is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) drug
CDSCO has published list of sixtyseven Drugs & Medicinal products as Not of Standard Quality
CDSCO has published list of drugs declared as spurious in the month of September 2024.
The European Medicines Agency (EMA) has initiated a review of finasteride and dutasteride due to
